Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Bioventures 2018 L.P. Mpm sold 28,837 shares of Entrada Therapeutics stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $7.13, for a total value of $205,607.81. Following the completion of the sale, the insider owned 3,885,115 shares […]

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Bioventures 2018 L.P. Mpm sold 38,500 shares of Entrada Therapeutics stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $7.11, for a total transaction of $273,735.00. Following the completion of the transaction, the insider directly […]

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Bioventures 2018 L.P. Mpm sold 192,500 shares of the stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $7.41, for a total value of $1,426,425.00. Following the completion of the transaction, the insider owned 3,913,952 shares in […]

Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Bioventures 2018 L.P. Mpm sold 3,733 shares of the business’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $7.01, for a total transaction of $26,168.33. Following the transaction, the insider directly owned 4,275,693 shares in the […]